Cetera Advisors LLC Senseonics Holdings, Inc. Transaction History

Cetera Advisors LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.5 - $0.73 $1,200 - $1,752	2,400 Added 20.17%	14,300 $7,000
Q2 2023 Aug 09, 2023	SELL	$0.55 - $0.89 $275 - $445	-500 Reduced 4.03%	11,900 $9,000
Q1 2023 May 15, 2023	BUY	$0.68 - $1.25 $748 - $1,375	1,100 Added 9.73%	12,400 $8,000
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $9,030 - $13,685	-3,500 Reduced 23.65%	11,300 $30,000
Q3 2021 Nov 16, 2021	BUY	$2.77 - $4.05 $9,664 - $14,130	3,489 Added 30.85%	14,800 $50,000
Q2 2021 Aug 13, 2021	SELL	$1.71 - $4.14 $1,691 - $4,094	-989 Reduced 8.04%	11,311 $43,000
Q1 2021 May 17, 2021	SELL	$0.85 - $5.27 $40,375 - $250,324	-47,500 Reduced 79.43%	12,300 $32,000
Q4 2020 Feb 17, 2021	BUY	$0.36 - $0.95 $1,080 - $2,850	3,000 Added 5.28%	59,800 $52,000
Q1 2020 May 08, 2020	SELL	$0.56 - $1.62 $1,120 - $3,240	-2,000 Reduced 3.4%	56,800 $36,000
Q4 2019 Feb 10, 2020	BUY	$0.83 - $1.3 $249 - $390	300 Added 0.51%	58,800 $56,000
Q2 2019 Aug 12, 2019	BUY	$1.81 - $2.45 $3,620 - $4,900	2,000 Added 3.54%	58,500 $118,000
Q1 2019 May 06, 2019	BUY	$2.3 - $3.27 $12,649 - $17,985	5,500 Added 10.78%	56,500 $133,000
Q3 2018 Nov 14, 2018	BUY	$3.4 - $4.84 $52,360 - $74,536	15,400 Added 43.26%	51,000 $246,000
Q2 2018 Aug 14, 2018	BUY	$3.03 - $4.98 $3,030 - $4,980	1,000 Added 2.89%	35,600 $146,000
Q4 2017 Feb 08, 2018	BUY	$2.43 - $3.54 $11,664 - $16,992	4,800 Added 16.11%	34,600 $94,000
Q3 2017 Nov 16, 2017	BUY	$2.22 - $3.2 $4,440 - $6,400	2,000 Added 7.19%	29,800 $95,000
Q2 2017 Aug 14, 2017	BUY	N/A	27,800	27,800 $50,000

138

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $410M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.